- Home
- GOVX vs CARV Comparison
GOVX vs CARV Comparison
Compare GOVX & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- CARV
- Stock Information
- Founded
- GOVX 2001
- CARV 1948
- Country
- GOVX United States
- CARV United States
- Employees
- GOVX N/A
- CARV N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- CARV Savings Institutions
- Sector
- GOVX Health Care
- CARV Finance
- Exchange
- GOVX Nasdaq
- CARV Nasdaq
- Market Cap
- GOVX 7.6M
- CARV 7.3M
- IPO Year
- GOVX N/A
- CARV 1994
- Fundamental
- Price
- GOVX $0.75
- CARV $2.38
- Analyst Decision
- GOVX Strong Buy
- CARV
- Analyst Count
- GOVX 4
- CARV 0
- Target Price
- GOVX $10.50
- CARV N/A
- AVG Volume (30 Days)
- GOVX 2.7M
- CARV 39.7K
- Earning Date
- GOVX 08-05-2025
- CARV 08-13-2025
- Dividend Yield
- GOVX N/A
- CARV N/A
- EPS Growth
- GOVX N/A
- CARV N/A
- EPS
- GOVX N/A
- CARV N/A
- Revenue
- GOVX $5,591,576.00
- CARV $21,046,000.00
- Revenue This Year
- GOVX N/A
- CARV N/A
- Revenue Next Year
- GOVX N/A
- CARV N/A
- P/E Ratio
- GOVX N/A
- CARV N/A
- Revenue Growth
- GOVX N/A
- CARV N/A
- 52 Week Low
- GOVX $0.43
- CARV $1.30
- 52 Week High
- GOVX $11.18
- CARV $2.56
- Technical
- Relative Strength Index (RSI)
- GOVX 47.67
- CARV 73.43
- Support Level
- GOVX $0.60
- CARV $1.79
- Resistance Level
- GOVX $0.76
- CARV $1.94
- Average True Range (ATR)
- GOVX 0.08
- CARV 0.15
- MACD
- GOVX 0.02
- CARV 0.02
- Stochastic Oscillator
- GOVX 59.45
- CARV 100.00
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.